 |
|
|
REFERENCES
151.
Anand KJS, Hansen DD, Hickey PR: Hormonal-metabolic
stress response in neonates undergoing cardiac surgery. Anesthesiology 73:661, 1990.
152.
Anand KJS, Sippell WG, Aynsley-Green A: Randomized
trial of fentanyl anesthesia in preterm neonates undergoing surgery: Effects on
the stress response. Lancet 1:243, 1987.
153.
Langercrantz H, Slotkin TA: The "stress" of being
born. Sci Am 1:100, 1986.
154.
Oshita S, Uchimoto R, Oka H, et al: Correlation
between arterial blood pressure and oxygenation in tetralogy of Fallot. J Cardiovasc
Anesth 3:597, 1989.
155.
Severinghaus JW, Spellman BA: Pulse oximeter
failure thresholds in hypotension and vasoconstriction. Anesthesiology 73:532, 1990.
156.
Gold JP, Jonas RA, Lang P, Castaneda A: Transthoracic
intracardiac monitoring lines in pediatric surgical patients: a ten year experience.
Ann Thorac Surg 42:185, 1986.
157.
Ungerleider R: Decision making in pediatric cardiac
surgery using intraoperative echo. Int J Cardiol Imaging 4:33, 1989.
158.
Greeley WJ, Kern FH, Ungerleider RM, Kisslo JA:
Intramyocardial air causes right ventricular dysfunction after repair of a congenital
heart defect. Anesthesiology 73:1042, 1990.
159.
Nakik SK, Knight A, Elliott MJ: A prospective
randomized study of a modified technique of ultrafiltration during pediatric open-heart
surgery. Circulation 84(suppl III):422, 1991.
160.
Elliott JJ: Ultrafiltration and modified ultrafiltration
in pediatric open-heart operations. Ann Thorac Surg 56:1518, 1993.
161.
Ungerleider RM: Effects of cardiopulmonary bypass
and use of modified ultrafiltration. Ann Thorac Surg 65:S35, 1998.
162.
Darling E, Nanry K, Shearer I, et al: Techniques
of paediatric modified ultrafiltration: 1996 survey results. Perfusion 13:93, 1998.
163.
Journois D, Pouard P, Greeley WJ, et al: Hemofiltration
during cardiopulmonary bypass in pediatric cardiac surgery. Anesthesiology 81:1181,
1994.
164.
Wang MJ, Chiu IS, Hsu CM, et al: Efficacy of
ultrafiltration in removing inflammatory mediators during pediatric cardiac operations.
Ann Thorac Surg 61:651, 1996.
165.
Friesen RH, Campbell DN, Clarke DR, Tornabene
MA: Modified ultrafiltration attenuates dilutional coagulopathy in pediatric open-heart
operation. Ann Thorac Surg 65:1787, 1997.
166.
Davies MJ, Nguyen K, Gaynor JW, Elliott MJ: Modified
ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary
bypass [discussion, 369]. J Thorac Cardiovasc Surg 115:361, 1998.
167.
Skaryak LA, Kirshbom PM, DiBernardo LR, et al:
Modified ultrafiltration improves cerebral metabolic recovery after circulatory
arrest. J Thorac Cardiovasc Surg 109:744, 1995.
168.
Koutlas TC, Gaynor JW, Nicolson SC, et al: Modified
ultrafiltration reduces postoperative morbidity after cavopulmonary connection.
Ann Thorac Surg 64:37, 1997.
169.
Daggett CW, Lodge AJ, Scarborough JE, et al:
Modified ultrafiltration versus conventional ultrafiltration: A randomized prospective
study in neonatal piglets. J Thorac Cardiovasc Surg 115:336, 1998.
170.
Borow KM, Green LH, Castaneda AR, Keane JF: Left
ventricular function after repair of tetralogy of Fallot and its relationship to
age at surgery. Circulation 61:1150, 1980.
171.
Berner M, Oberhansli I, Rouge JC, Jaccard C:
Chronotropic and inotropic supports are both required to increase cardiac output
early after corrective operations for tetralogy of Fallot. J Thorac Cardiovasc Surg
97:297, 1989.
172.
Graham TP, Franklin RCG, Wyse RKH, et al: Left
ventricular wall stress and contractile function in childhood: Normal values and
comparison of Fontan repair versus palliation only in patients with tricuspid atresia.
Circulation 74:61, 1986.
173.
Lang P, Williams RG, Norwood WI: The hemodynamic
effects of dopamine in infants after corrective cardiac surgery. J Pediatr 96:630,
1980.
174.
Rebeyka IM, Hanan SA, Borges MR, et al: Rapid
cooling contracture of the myocardium: The adverse effect of prearrest cardiac hypothermia.
J Thorac Cardiovasc Surg 100:240, 1990.
175.
Bohn DJ, Poirer CS, Edmonds JF: Efficacy of dopamine,
dobutamine, and epinephrine during emergence from cardiopulmonary bypass in children.
Crit Care Med 8:367, 1980.
176.
Konstam MA, Cohen SR, Salem DN: Effect of amrinone
on right ventricular function: predominance of afterload reduction. Circulation
74:359. 1986.
177.
Wessel DL, Triedman JK, Wernovsky G: Pulmonary
and systemic hemodynamics of amrinone in neonates following cardiopulmonary bypass.
Circulation 80(Suppl II):488, 1989.
178.
Lawless S, Burckart G, Diven W: Amrinone pharmacokinetics
in neonates and infants. J Clin Pharmacol 28:283, 1988.
179.
Williams GD, Sorensen GK, Oakes R, et al: Amrinone
loading during cardiopulmonary bypass in neonates, infants, and children. J Cardiothorac
Vasc Anesth 9:278, 1995.
180.
Chang AC, Atz AM, Wernovsky G, et al: Milrinone:
Systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit
Care Med 23:1907, 1995.
181.
Ramamoorthy C, Anderson GD, Williams GD, Lynn
AM: Pharmacokinetics and side effects of milrinone in infants and children after
open-heart surgery. Anesth Analg 86:283, 1998.
182.
Driscoll DJ, Gillette PC, Fukushige J, et al:
Comparison of the cardiovascular action of isoproterenol, dopamine and dobutamine
in the neonatal and mature dog. Pediatr Cardiol 1:307, 1980.
183.
Friedman WF: The intrinsic properties of the
developing heart. Prog Cardiovasc Dis 15:87, 1972.
184.
Hines R, Barash PG: Right ventricular failure.
In Kaplan JA (ed): Cardiac Anesthesia, vol 2.
Orlando, Fla., Grune & Stratton, 1987, p 995.
185.
Berne RM, Levy MN: Coronary circulation and cardiac
metabolism. In Berne RM, Levy MN (eds): Cardiovascular
Physiology. St. Louis, Mosby, 1981, p 211.
186.
Rudolph AM: Distribution and regulation of blood
flow in the fetal and newborn lamb. Circ Res 57:811, 1985.
187.
Pearl JM, Laks H, Drinkwater DC, et al: Repair
of truncus arteriosus in infancy. Ann Thorac Surg 52:780, 1991.
188.
Klein MD, Shaheen KW, Whittlesey GC, et al: Extracorporeal
membrane oxygenation for the circulatory support of children after repair of congenital
heart disease. J Thorac Cardiovasc Surg 100:498, 1990.
189.
Golding LAR: Postcardiotomy mechanical support.
Semin Thorac Cardiovasc Surg 3:29, 1991.
190.
Walters HL 3rd, Hakimi M, Rice MD, et al: Pediatric
cardiac surgical ECMO: Multivariate analysis of risk factors for hospital death
[discussion, 336]. Ann Thorac Surg 60:329, 1995.
191.
Meliones JN, Custer JR, Snedecor S, et al: Extracorporeal
life support for cardiac assist in pediatric patients. Review of ELSO Registry data.
Circulation 84(5 Suppl):III-168, 1991.
192.
Duncan BW, Ibrahim AE, Hraska V, et al: Use of
rapid-deployment extracorporeal membrane oxygenation for the resuscitation of pediatric
patients with heart disease after cardiac arrest. J Thorac Cardiovasc Surg 116:305,
1998.
193.
Karl TR: Extracorporeal circulatory support in
infants and children. Semin Thorac Cardiovasc Surg 6:54, 1994.
194.
Drummond WH, Gregory GA, Heymann MA, Phibbs RA:
The independent effects of hyperventilation, tolazoline and dopamine on infants
with persistent pulmonary hypertension. J Pediatr 98:603, 1981.
195.
Custer JR, Hales CA: Influence of alveolar oxygen
on pulmonary vasoconstriction in newborn lambs vs sheep. Am Rev Respir Dis 132:326,
1985.
196.
Lyrene RK, Welch KA, Godoy G, Philips JB: Alkalosis
attenuates hypoxic pulmonary vasoconstriction in neonatal lambs. Pediatr Res 19:1268,
1985.
197.
Rudolph AM, Yuan S: Response of the pulmonary
vasculature to hypoxia and H ion concentration changes. J Clin Invest 45:399, 1966.
198.
Zapletal A, Paul T, Samenek M: Pulmonary elasticity
in children and adolescents. J Appl Physiol 40:953, 1976.
199.
Fagan DG: Shape changes in V-P loops for children's
lungs related to growth. Thorax 32:198, 1977.
200.
Mansell A, Bryan C, Levinson H: Airway closure
in children. J Appl Physiol 33:711, 1972.
201.
Hammond JW, Wolfe WG, Moran JF, et al: The effect
of positive end expiratory pressure on regional ventilation and perfusion in the
normal and injured primate lung. J Thorac Cardiovasc Surg 72:680, 1976.
202.
Weisfeldt ML, Halperin HR: Cardiopulmonary resuscitation:
Beyond cardiac massage. Circulation 74:443, 1986.
203.
Molloy DW: Effects of noradrenaline and isoproterenol
on cardiopulmonary function in a canine model of acute pulmonary hypertension. Chest
88:432, 1985.
204.
Schwartz DA, Grove FL, Horowitz LD: Effect of
isoproterenol on regional myocardial perfusion and tissue oxygenation in acute myocardial
infarction. Am Heart J 97:339, 1979.
205.
Park IS, Michael LH, Driscoll DJ: Comparative
responses of the developing canine myocardium to inotropic agents. Am J Physiol
242:H13, 1982.
206.
Heymann MA, Hoffman JIE: Persistent pulmonary
hypertension syndromes in the newborn. In Weir EK,
Reeves JT (eds): Pulmonary Hypertension. Mt. Kisko, NY, Futura, 1984, p 45.
207.
Bush A, Busset C, Knight WB, et al: Modification
of pulmonary hypertension secondary to congenital heart disease. Am Rev Respir Dis
136:767, 1987.
208.
Zall S, Milocco I, Rickstein S-E: Effects of
adenosine on myocardial blood flow and metabolism after coronary artery bypass surgery.
Anesth Analg 73:689, 1991.
209.
Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et
al: Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary
hypertension. Lancet 338(8776):1173, 1991.
210.
Girard C, Lehot JJ, Clerc J, French P: Inhaled
nitric oxide (NO) in pulmonary hypertension following mitral valve replacement.
Anesthesiology 75:A984, 1991.
211.
Russell IA, Zwass MS, Fineman JR et al: The effects
of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children
undergoing surgical repair of congenital heart disease. Anesth Analg 87:46, 1998.
212.
Curran RD, Mavroudis C, Backer CL, et al: Inhaled
nitric oxide for children with congenital heart disease and pulmonary hypertension.
Ann Thorac Surg 60:1765, 1995.
213.
Wessel DL, Adatia I, Giglia TM, et al: Use of
inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension
and endothelial function after cardiopulmonary bypass. Circulation 88(5 Pt 1):2128,
1993.
214.
Zobel G, Gamillscheg A, Schwinger W, et al: Inhaled
nitric oxide in infants and children after open-heart surgery. J Cardiovasc Surg
39:79, 1998.
215.
Adatia I, Perry S, Landzberg M, et al: Inhaled
nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before
transplantation. J Am Coll Cardiol 25:1656, 1995.
216.
Adatia I, Atz AM, Jonas RA, Wessel DL: Diagnostic
use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc
Surg 112:1403, 1996.
217.
Manno CS, Hedberg KW, Kim HC, et al: Comparison
of the hemostatic effects of fresh whole blood, stored whole blood, and components
after open heart surgery in children. Blood 77:930, 1991.
218.
Dietrich W, Mossinger H, Spannagl M, et al: Hemostatic
activation during cardiopulmonary bypass with different aprotinin dosages in pediatric
patients having cardiac operations. J Thorac Cardiovasc Surg 105:712, 1993.
219.
Andrew M, Paes B, Milner R, et al: Development
of the human coagulation system in the full-term infant. Blood 70:165, 1987.
220.
Colon-Otero G, Gilchrist GS, Holcomb GR, et al:
Preoperative evaluation of hemostasis in patients with heart disease. Mayo Clin
Proc 62:379, 1987.
221.
Henriksson P, Varendh G, Lundstrom NR: Haemostatic
defects in cyanotic congenital heart disease. Br Heart J 41:23, 1979.
222.
Vieira A, Berry L, Ofoso F, Andrew M: Heparin
sensitivity and resistance in the neonate: An explanation. Thromb Res 63:85, 1991.
223.
Kern FH, Morana NJ, Sears J, Hickey PR: Coagulation
defects in neonates during CPB. Ann Thorac Surg 54:541, 1992.
224.
Horkay F, Martin P, Rajah SM, Walker DR: Response
to heparinization in adults and children undergoing cardiac operations. Ann Thorac
Surg 53:822, 1992.
225.
Jobes DR, Shaffer GW, Aitken GL: Increased accuracy
and precision of heparin and protamine dosing reduces blood loss and transfusion
in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg 110:36,
1995.
226.
Harker LA: Bleeding after cardiopulmonary bypass.
N Engl J Med 314:446, 1986.
227.
Woodman RC, Harker LA: Bleeding complications
associated with cardiopulmonary bypass. Blood 76:1680, 1990.
228.
Salzman EW, Weinstein MJ, Weintraub RM, et al:
Treatment with desmopressin acetate to reduce blood loss after cardiac surgery.
N Engl J Med 314:1402, 1986.
229.
Reynolds LM, Nicolson SC, Jobes DR, et al: Desmopressin
does not decrease bleeding after cardiac operation in young children. J Thorac Cardiovasc
Surg 106:954, 1993.
230.
Horrow JC, Hlavacek J, Strong MD, et al: Prophylactic
tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc
Surg 99:70, 1990.
231.
Royston D, Taylor KM, Bidstrup BP, Sapsford RN:
Effect of aprotinin on need for blood transfusion after repeat open-heart surgery.
Lancet 2:1289, 1987.
232.
Dietrich W, Henze R, Barankay A, et al: High-dose
aprotinin application reduces homologous blood requirement in cardiac surgery. J
Cardiothorac Anesth 3:79, 1989.
233.
Dietrich W, Spannagl M, Jochum M, et al: Influence
of high-dose aprotinin treatment on blood loss and coagulation patterns in patients
undergoing myocardial revascularization. Anesthesiology 73:1119, 1990.
234.
Dietrich W, Spannagl M, Schramm W, et al: The
influence of preoperative anticoagulation on heparin response during cardiopulmonary
bypass. J Thorac Cardiovasc Surg 102:505, 1991.
235.
Dietrich W, Barankay A, Hahnel C, Richter JA:
High-dose aprotinin in cardiac surgery: Three years' experience in 1,784 patients.
J Cardiothorac Vasc Anesth 6:324, 1992.
236.
Davies MJ, Allen A, Kort H, et al: Prospective,
randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations.
Ann Thorac Surg 63:497, 1997.
237.
Penkoske PA, Entwistle LM, Marchak BE, et al:
Aprotinin in children undergoing repair of congenital heart defects. Ann Thorac
Surg 60(6 Suppl):S529, 1995.
238.
Carrel TP, Schwanda M, Bogt PR, Turina MI: Aprotinin
in pediatric cardiac operations: A benefit in complex malformations and with high-dose
regimen only. Ann Thorac Surg 66:153, 1998.
239.
Kirklin JW, Archie JP Jr: The cardiovascular
subsystem in surgical patients. Surg Gynecol Obstet 139:17, 1974.
240.
Hosenpud JD, Bennett LE, Berkeley M, et al: The
registry of the international society for heart and lung transplantation: Fifteenth
official report 1998. J Heart Lung Transplant 17:656, 1998.
241.
Kirklin JK, Naftel DC, McGiffin DC, et al: Analysis
of morbid events and risk factors for death after cardiac transplantation. J Am
Coll Cardiol 11:917, 1998.
242.
Gajarski RJ, Towbin JA, Bricker JT, et al: Intermediate
follow-up of pediatric heart transplant recipients with elevated pulmonary vascular
resistance index. J Am Coll Cardiol 23:1682, 1994.
243.
Fukushima N, Gundry SR, Razzouk AJ, Bailey LL:
Risk factors for graft failure associated with pulmonary hypertension after pediatric
heart transplantation. J Thorac Cardiovasc Surg 107:985, 1994.
244.
Bailey LL: Heart transplantation techniques in
complex congenital heart disease. J Heart Lung Transplant 12(6 Pt 2):S168, 1993.
245.
Chartrand C, Guerin R, Kangah M, Stanley P: Pediatric
heart transplantation: Surgical considerations for congenital heart diseases [discussion,
616]. J Heart Transplant 9:608, 1990.
246.
Zales VR, Wright KL, Pahl E, et al: Normal left
ventricular muscle mass and mass/volume ratio after pediatric cardiac transplantation.
Circulation 90(5 Pt 2):II61, 1994.
247.
Canter CE, Moorhead S, Saffitz JE, et al: Steroid
withdrawal in the pediatric heart transplant recipient initially treated with triple
immunosuppression [discussion, 79]. J Heart Lung Transplant 12(1 Pt 1):74, 1994.
248.
Boucek MM, Kanakriyeh MS, Mathis CM, et al: Cardiac
transplantation in infancy: Donors and recipients. Loma Linda University Pediatric
Heart Transplant Group. J Pediatr 116:171, 1990.
249.
Bridges ND, Malory GB Jr, Huddleston CB, et al:
Lung transplantation in children and young adults with cardiovascular disease [discussion,
820]. Ann Thorac Surg 59:813, 1995.
250.
Conte JV, Robbins RC, Reichenspurner H, et al:
Pediatric heart-lung transplantation: intermediate-term results. J Heart Lung
Transplant 15:692, 1996.
251.
Burke RP, Wernovsky G, van der Velde M, et al:
Video-assisted thoracoscopic surgery for congenital heart disease [discussion, 508].
J Thorac Cardiovasc Surg 109:499, 1995.
252.
Laborde F, Folliguet T, Batisse A, et al: Video-assisted
thoracoscopic surgical interruption: The technique of choice for patent ductus arteriosus.
Routine experience in 230 pediatric cases [discussion, 1684]. J Thorac Cardiovasc
Surg 110:1681, 1995.
253.
Gelman S, Reves JG, Fowler K, et al: Regional
blood flow during cross-clamping of the thoracic aorta and infusion of sodium nitroprusside.
J Thorac Cardiovasc Surg 85:287, 1983.
254.
DeSanctis RW, Doroghazi RM, Austen WG, Buckley
JJ: Aortic dissection. N Engl J Med 317:1060, 1987.
255.
Mullins CE: Pediatric and congenital therapeutic
cardiac catheterization. Circulation 79:1153, 1989.
256.
Hellenbrand WE, Fahey JT, McGowan FX et al: Transesophageal
echocardiographic guidance for transcatheter closure of atrial septal defects. Am
J Cardiol 66:207, 1990.
257.
Lock JE, Rome JJ, Davis R, et al: Transatrial
closure of atrial septal defects: Experimental studies. Circulation 79:1091, 1989.
258.
Hickey PR, Wessel DL, Streitz SL et al: Transcatheter
closure of atrial septal defects: Hemodynamic complications and anesthetic management.
Anesth Analg 74:44, 1992.
259.
Malviya S, Burrows FA, Johnston AE, Benson LN:
Anaesthetic experience with paediatric interventional cardiology. Can J Anaesth
36:320, 1989.
260.
Rothman A, Perry SB, Keane JF, Lock JE: Early
results and follow-up of balloon angioplasty for branch pulmonary artery stenoses.
J Am Coll Cardiol 15:1109, 1990.
